Sort
130,381 grants matching “hiv”
AIDS and Cancer Virus Program (ACVP)
$15,476,083Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
HVTN Laboratory Program
$15,461,760Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)
$15,407,150Lisa P Jacobson · Johns Hopkins University · U24 · FY2022 · OD
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
$15,396,723Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
IMPAACT Leadership Group
$15,388,321Sharon A Nachman · Johns Hopkins University · UM1 · FY2022 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$15,358,934Felipe Rocha · Texas State Dept Of Health Services · U62 · FY2013 · PS
NIAID/Division of AIDS: Regulatory Support Center
$15,247,125Asimah Rafi · Technical Resources International, Inc. · N01 · FY2021 · AI
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
$15,244,065Mary Custer · Division Of Basic Sciences - Nci · ZIG · FY2021 · CA
HIV Vaccine Research and Development - NIAID DAIDS Vaccine Research Program
$15,135,057National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
Therapeutics/Vaccine Teams
$15,067,360Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2010 · AI
Statistical and Data Management Center for the AIDS Clinical Trials Group
$15,061,511Michael David Hughes · Harvard School Of Public Health · UM1 · FY2012 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$14,994,115Michael David Hughes · Harvard School Of Public Health · UM1 · FY2020 · AI
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab
$14,980,054Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Production of a Broadly Neutralizing HIV Antibodies
$14,973,939Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2018 · AI
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$14,928,508James M Tesoriero · Nysdoh/Health Research, Inc. · U62 · FY2015 · PS
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$14,926,018Felipe Rocha · Texas State Dept Of Health Services · U62 · FY2015 · PS
(CHAVI) Center for HIV/AIDS Vaccine Immunology
$14,900,000Duke University · U01 · FY2005 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$14,844,618Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
LOC-IMPAACT Leadership Group
$14,793,228Sharon A Nachman · Johns Hopkins University · UM1 · FY2014 · AI
Statistical and Data Management Center for the AIDS Clinical Trials Group
$14,780,954Michael David Hughes · Harvard School Of Public Health · U01 · FY2006 · AI
COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
$14,755,857Social And Scientific Systems, Inc. · U01 · FY2003 · AI
AIDS Clinical Trial Group Laboratory Center
$14,702,977Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2025 · AI
LC: HIV Vaccine Trials Network
$14,697,164Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$14,687,503Mario Perez · Los Angeles County Public Health Department · U62 · FY2013 · PS
Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC)
$14,665,190George R Seage · Harvard School Of Public Health · U01 · FY2013 · HD